Related Experiment Video
Updated: Jun 4, 2026

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
Published on: September 17, 2013
Construction of porA Mutants
1Laboratory of Vaccine Research, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
Abstract:
The PorA or class 1 protein is one of the major meningococcal outermembrane proteins (OMPs). It is one of the two porins found in this organism, the other one being the PorB or class 2/3 protein. It folds into a 16-stranded β-barrel structure, which is now well-established for bacterial porins, in which seven loops are exposed at the cell surface and the remaining one forms the constriction of the pore (1,2). There are approx 20 different serosubtypes of PorA (3), based on sequence variability in the longest surface-exposed loops 1 and 4 (see Fig. 1). In addition, minor sequence variations within individual subtypes have been observed. As a result, some subtypes such as P1.10 actually constitute a family of variants differing by single amino acid substitutions, which may affect antibody recognition; for other subtypes such as P1.4 the number of variants is more limited (4,5). Several studies with experimental outer membrane-derived vaccines have shown that PorA is a major inducer of bactericidal antibodies (6-8), making it a crucial component of any meningococcal vaccine. These antibodies are highly subtype-specific. Epidemic strains tend to be clonal and mainly express a single PorA subtype that changes only slowly over time (9). In hyperendemic situations, more variation is found but it is generally still possible to select a limited number of PorA subtypes that will cover most of the strains (10). However, PorA variation in both time and geography means that it is unlikely that a universal once-and-for-all meningococcal vaccine based on this protein alone can ever be made. This necessitates the use of vaccine strains with flexible PorA composition, in which new variants can be inserted into established production strains when required by new epidemiological circumstances. This chapter will describe methods to construct isogenic meningococcal strains with altered porA genes, which can be used both for vaccine production and as test strains to determine the precise epitope specificity of bactericidal antibodies directed against the various loops of PorA. Fig. 1. Topology model for PorA protein. Residues shown in boldface represent the surface-exposed P1.5 and P1.2 epitopes in loop 1 and 4. Residues marked with an asterisk represent the points of insertion into the KpnI site in loop 5 or 6.
Insights
PorA, a key outer membrane protein in meningococcus, induces subtype-specific bactericidal antibodies. Its variability necessitates flexible vaccine strategies, requiring methods to construct strains with altered PorA genes for vaccine production and antibody testing.
Area of Science:
- Microbiology and Immunology
- Vaccine Development
Background:
- PorA (class 1 protein) is a major outer membrane protein (OMP) and porin in *Neisseria meningitidis*.
- It forms a β-barrel structure with surface-exposed loops, crucial for antibody recognition.
- Approximately 20 PorA serosubtypes exist, with variations in surface-exposed loops 1 and 4.
Purpose of the Study:
- To describe methods for constructing isogenic meningococcal strains with altered *porA* genes.
- To enable flexible PorA composition in vaccine strains for evolving epidemiological circumstances.
- To develop test strains for determining epitope specificity of bactericidal antibodies against PorA.
Main Methods:
- Construction of isogenic meningococcal strains with modified *porA* genes.
- Utilizing specific insertion sites (e.g., KpnI in loop 5 or 6) for genetic alterations.
- Characterization of altered strains for vaccine production and immunological studies.
Main Results:
- Demonstrated feasibility of creating meningococcal strains with altered PorA variants.
- Established methods for manipulating *porA* gene composition in production strains.
- Facilitated precise epitope mapping of bactericidal antibodies against PorA.
Conclusions:
- PorA's significant role in inducing bactericidal antibodies makes it a critical vaccine target.
- The high degree of PorA variability necessitates adaptable vaccine platforms.
- Developed methods support the creation of flexible meningococcal vaccines and advanced immunological assays.
Related Concept Videos
Porin Insertion in the Outer Mitochondrial Membrane
Three models describe the assembly of porins by the SAM complex and their insertion into the outer membrane. Model 1 suggests that porins are assembled outside the SAM channel as the...
Structure of Porins
In-vitro Mutagenesis
In vitro Mutagenesis
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations

